72/100 · Elevated
4,882 FDA adverse event reports
TROSPIUM CHLORIDE is manufactured by Padagis US LLC and is tracked in the FDA Adverse Event Reporting System (FAERS). There are 4,882 adverse event reports for TROSPIUM CHLORIDE in the FDA database. Based on our AI analysis, TROSPIUM CHLORIDE has a safety score of 72 out of 100.
This page focuses specifically on TROSPIUM CHLORIDE as manufactured by Padagis US LLC, providing safety context within the manufacturer's broader drug portfolio. Different manufacturers of the same active ingredient may have different adverse event profiles due to variations in formulation, inactive ingredients, manufacturing processes, and patient populations.
The following adverse reactions have been most frequently reported for TROSPIUM CHLORIDE manufactured by Padagis US LLC:
Out of 2,140 classified reports for TROSPIUM CHLORIDE:
Explore other medications manufactured by Padagis US LLC in the FDA adverse event database:
The most commonly reported side effects of TROSPIUM CHLORIDE include FALL, FATIGUE, URINARY TRACT INFECTION. These are based on 4,882 FDA adverse event reports.
TROSPIUM CHLORIDE has a safety score of 72/100 based on AI analysis of FDA adverse event reports. Always discuss medication risks with your healthcare provider.